Drug Trial Radar · NCT00434096
Japanese Study of Rimonabant in Obese Patients With Dyslipidemia (VENUS)
Last checked: Nov 20, 2026Latest source record: Jul 20, 2009 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
915
Actual
Start
Feb 2007
Primary completion
Nov 2008
Study completion Feb 2009
Sponsor
- Lead sponsor
- SanofiSanofi (SNY)
- Sponsor type
- Industry
- First posted
- Feb 12, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to assess the efficacy of SR141716 compared to placebo on body weight and triglycerides changes over a period of 52 weeks. Secondary objectives are: * To evaluate the effect of SR141716 compared to placebo over a period of 52 weeks, on HDL-cholesterol and visceral fat area. * To evaluate the safety of SR141716 compared to placebo over a period of 104 weeks. * To evaluate the pharmacokinetics of SR141716.
Conditions
- Obesity
Interventions
rimonabant (SR141716)Drug
oral administration once daily
placeboDrug
oral administration once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- body weight: relative change from baselineTime frame: Week 52
- triglycerides: relative change from baselineTime frame: Week 52
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Sanofi-Aventis Administrative Office
Tokyo, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.